Peter Heerma, CHIEF COMMERCIAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 8,210 shares at $23.53 ($198K) on 2025-02-12, disclosed to the SEC on 2025-02-12.
Scheduled sale ($198k) by CHIEF COMMERCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 3,074 | $77K | 38.9% |
| 2 | $23.53 | 2,568 | $60K | 30.6% |
| 3 | $23.53 | 2,568 | $60K | 30.6% |
| Total | $24.08 avg | 8,210 | $198K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $303K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $235K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |